Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$12.00 | Vjjmms | Jpsfqwhxm |
Bio-Techne Buoyed by Growing Demand for Cell and Gene Therapies, Long-Term Goals on Track
Business Strategy and Outlook
Bio-Techne is a market leader in proteins for the pharma, biotech, academic, and diagnostic markets and maintains strong market positioning in antibodies and testing controls for diagnostic partners.